RS52237B - Rastvor za peritonealnu dijalizu koji sadrži karnitin i ima poboljšanu biokompatibilnost - Google Patents

Rastvor za peritonealnu dijalizu koji sadrži karnitin i ima poboljšanu biokompatibilnost

Info

Publication number
RS52237B
RS52237B RS20120096A RSP20120096A RS52237B RS 52237 B RS52237 B RS 52237B RS 20120096 A RS20120096 A RS 20120096A RS P20120096 A RSP20120096 A RS P20120096A RS 52237 B RS52237 B RS 52237B
Authority
RS
Serbia
Prior art keywords
peritoneal dialysis
carnitine
solution according
acid
glucose
Prior art date
Application number
RS20120096A
Other languages
English (en)
Serbian (sr)
Inventor
Arduino Arduini
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of RS52237B publication Critical patent/RS52237B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
RS20120096A 2005-03-10 2006-02-22 Rastvor za peritonealnu dijalizu koji sadrži karnitin i ima poboljšanu biokompatibilnost RS52237B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2005000130 2005-03-10
PCT/EP2006/060162 WO2006094900A1 (en) 2005-03-10 2006-02-22 Carnitine-containing peritoneal dialysis solution having improved biocompatibility

Publications (1)

Publication Number Publication Date
RS52237B true RS52237B (sr) 2012-10-31

Family

ID=35159907

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20120096A RS52237B (sr) 2005-03-10 2006-02-22 Rastvor za peritonealnu dijalizu koji sadrži karnitin i ima poboljšanu biokompatibilnost

Country Status (19)

Country Link
US (1) US20080138443A1 (cg-RX-API-DMAC10.html)
EP (1) EP1858504B1 (cg-RX-API-DMAC10.html)
JP (2) JP4717110B2 (cg-RX-API-DMAC10.html)
KR (1) KR101324920B1 (cg-RX-API-DMAC10.html)
AR (1) AR054015A1 (cg-RX-API-DMAC10.html)
AT (1) ATE539742T1 (cg-RX-API-DMAC10.html)
CA (1) CA2599252C (cg-RX-API-DMAC10.html)
CY (1) CY1112794T1 (cg-RX-API-DMAC10.html)
DK (1) DK1858504T3 (cg-RX-API-DMAC10.html)
ES (1) ES2380168T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20120177T1 (cg-RX-API-DMAC10.html)
ME (1) ME02948B (cg-RX-API-DMAC10.html)
MX (1) MX2007010814A (cg-RX-API-DMAC10.html)
PL (1) PL1858504T3 (cg-RX-API-DMAC10.html)
PT (1) PT1858504E (cg-RX-API-DMAC10.html)
RS (1) RS52237B (cg-RX-API-DMAC10.html)
SI (1) SI1858504T1 (cg-RX-API-DMAC10.html)
TW (1) TWI388318B (cg-RX-API-DMAC10.html)
WO (1) WO2006094900A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365429B1 (es) * 2010-03-05 2012-09-06 Universidad De Castilla De La Mancha Solucion para dialisis peritoneal
WO2018031922A1 (en) * 2016-08-11 2018-02-15 Sulfilatec, Inc. Medical and nutritional compositions and methods of use
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica
EP3912656A1 (en) 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
GB9714218D0 (en) * 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
EP1009452A4 (en) * 1997-08-07 2004-03-31 Ajay Gupta WATER-SOLUBLE VITAMINS AND DIALYSIS SOLUTION CONTAINING NUTRIENTS
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
MXPA02003635A (es) * 1999-10-11 2002-10-23 Sigma Tau Ind Farmaceuti Uso de l-carnitina y sus derivados de alcanoilo como agentes osmoticos en soluciones para uso medico.
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) * 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
JP2004016615A (ja) * 2002-06-19 2004-01-22 Fuso Pharmaceutical Industries Ltd 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液
US20060046975A1 (en) 2002-12-10 2006-03-02 Ola Carlsson Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Ｌカルニチン含有腹膜透析液

Also Published As

Publication number Publication date
TWI388318B (zh) 2013-03-11
EP1858504A1 (en) 2007-11-28
EP1858504B1 (en) 2012-01-04
KR20070116630A (ko) 2007-12-10
JP5366894B2 (ja) 2013-12-11
DK1858504T3 (da) 2012-04-30
US20080138443A1 (en) 2008-06-12
PL1858504T3 (pl) 2012-05-31
TW200714279A (en) 2007-04-16
ATE539742T1 (de) 2012-01-15
CA2599252A1 (en) 2006-09-14
PT1858504E (pt) 2012-04-10
HRP20120177T1 (hr) 2012-03-31
AR054015A1 (es) 2007-05-30
CY1112794T1 (el) 2016-02-10
KR101324920B1 (ko) 2013-11-01
CA2599252C (en) 2013-07-30
JP2008532601A (ja) 2008-08-21
ME02948B (me) 2012-10-31
JP4717110B2 (ja) 2011-07-06
WO2006094900A1 (en) 2006-09-14
SI1858504T1 (sl) 2012-04-30
ES2380168T3 (es) 2012-05-09
MX2007010814A (es) 2007-11-07
JP2010207630A (ja) 2010-09-24

Similar Documents

Publication Publication Date Title
TW287108B (cg-RX-API-DMAC10.html)
Bito et al. On the physiological response of the cerebral cortex to acute stress (reversible asphyxia)
US20090018136A1 (en) Methods and compositions for the treatment of vascular disease
EA025137B1 (ru) Раствор для диализа, включающий одно или более соединений креатина и способ его получения
US8129430B2 (en) Method of reducing phosphate nephropathy in a mammal
Muller et al. Lung procurement by low-potassium dextran and the effect on preservation injury
US20210145797A1 (en) Compositions for treating skin
JP5366894B2 (ja) 生体適合性が改善されたカルニチンを含有する腹膜透析液
KR0178799B1 (ko) 면역계 활성을 증가시키기 위한 약학 조성물
CN102083443B (zh) 调节肌动蛋白细胞骨架重排和细胞间间隙形成的方法
EP1572182B1 (en) Composition for the treatment of gastrointestinal disorders
JP3182564B2 (ja) 栄養組成物
KOGUT et al. Tyrosinosis
RU2521199C1 (ru) Фармацевтическая композиция для профилактики и лечения сосудистых нарушений и нейропатий
CN120513929A (zh) 一种可于常温保存离体动物器官或离体动物组织的保护液及其制备方法和应用
US20070037777A1 (en) Lipid-containing compositions and methods of using them
JP2010260808A (ja) 肌状態改善用経口医薬組成物
Kilburn et al. Neonatal deaths and pulmonary dysplasia due to D‐penicillamine in the rat
CN113905726B (zh) 能够激活蛋白质Klotho产生的包含柠檬酸盐和肉碱的组合物
Bocock et al. Hepatic sulfur amino acid metabolism in rats with chronic renal failure
MXPA02000912A (es) Uso de l-carnitina y sus derivados alcanoilo para la preparacion de un medicamento util para el tratamiento de pacientes que sufren nefropatias diabeticas o por insuficiencia metabolica.
JP6811983B2 (ja) 網膜神経節細胞死抑制活性を有する経口用組成物
HK40117744A (en) Therapeutic agent for renal disease, renal function-improving agent
JPH0733601A (ja) 組織保存用組成物
JP5756498B2 (ja) 変形性関節症予防治療薬